Medistim ASA (STO:MEDIO)

Market Cap	5.43B +32.1%
Revenue (ttm)	736.59M +18.6%
Net Income	161.73M +26.0%
EPS	8.85 +26.1%
Shares Out	n/a
PE Ratio	33.54
Forward PE	28.44
Dividend	n/a
Ex-Dividend Date	n/a

Volume	166
Open	280.00
Previous Close	268.00
Day's Range	280.00 - 290.00
52-Week Range	188.00 - 290.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 159
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2025, Medistim ASA's revenue was 699.77 million, an increase of 24.38% compared to the previous year's 562.60 million. Earnings were 159.21 million, an increase of 53.33%.

Financial numbers in NOK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 13, 2026

Data Sources Report a data error